Back
Edgewise Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
46
EWTX
Edgewise Therapeutics
Last Price:
$29.19
Seasonality Move:
26.98%
Sell
42
SRPT
Sarepta Therapeutics
Last Price:
$122.64
Seasonality Move:
9.24%
Sell
46
Edgewise Therapeutics (EWTX)
is a Sell
Is Edgewise Therapeutics a Buy, Sell or Hold?
-
The current Edgewise Therapeutics [EWTX] share price is $29.62. The Score for EWTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
EWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $121.90. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $29.62Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $121.90Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.57 | Sell |
Relative Strength Index (14 RSI): | 44.56 | Sell |
Chaikin Money Flow: | 1558 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.66 - 32.42) | Sell |
Bollinger Bands (100): | (20.17 - 33.79) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 48.37 | Sell |
Chaikin Money Flow: | 152096 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (115.83 - 130.31) | Sell |
Bollinger Bands (100): | (118.21 - 135.05) | Sell |
EWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.2 | Sell |
20-day SMA: | 30.81 | Sell |
50-day SMA: | 32.64 | Sell |
200-day SMA: | 22.49 | Buy |
8-day EMA: | 30.19 | Sell |
20-day EMA: | 30.74 | Sell |
50-day EMA: | 30.54 | Sell |
200-day EMA: | 23.69 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.19 | Sell |
20-day SMA: | 125.99 | Sell |
50-day SMA: | 122.9 | Sell |
200-day SMA: | 129.63 | Sell |
8-day EMA: | 122.01 | Sell |
20-day EMA: | 122.84 | Sell |
50-day EMA: | 123.52 | Sell |
200-day EMA: | 125.9 | Sell |
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.30 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.
Edgewise Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |